Earnings · China A-shares

Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A (603392) earnings

Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A published its Q3 report on 2026-10-26: net profit -33.07% year on year, +6.99% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -10.16% in the 3 trading days after the report.

Report
Q3 report
Published
2026-10-26
Period end
2026-09-30
Net profit YoY
-33.07%
Excl. one-offs YoY
+6.99%
Result
Bad / loss
Quality score
59
Quality
Questionable
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-9.97%—
3 days-10.16%—
7 days-4.58%—
14 days-11.40%—

Report history

Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 4 of 8 reports (average -0.21%).

ReportPublishedNet profitProfit YoYExcl. one-offs YoYRevenue YoYEPSROE3 days after30 days after30d vs index
2026 Q3 report2026-10-27-¥230.77M-33.07%+6.99%+8.29%-0.18-1.96%-10.16%——
2026 interim report2026-08-20-¥128.32M+10.92%+30.39%+24.29%-0.10-1.09%+0.29%-5.39%+0.30%
2026 Q1 report2026-04-28-¥42.98M+18.56%+38.49%+30.63%-0.03-0.36%-1.23%-27.29%-26.67%
2025 annual report2026-04-21-¥398.27M-474.89%—-18.99%-0.31-3.30%-4.91%-17.26%-20.71%
2025 Q3 report2025-10-30-¥173.42M-165.04%—-23.09%-0.14-1.42%-0.83%-14.97%-10.23%
2025 interim report2025-08-21-¥144.04M-155.30%—-38.25%-0.11-1.18%+9.79%+2.34%-8.34%
2025 Q1 report2025-04-25-¥52.78M-141.98%—-46.76%-0.04-0.43%+0.66%+4.02%+0.78%
2024 annual report2025-04-12¥106.24M-91.49%—-59.25%0.080.85%+4.69%+0.90%-1.79%

The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.

Stock valuations: 603392

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.